Four Children with Multidrug-resistant Acinetobactor baumanii Infections in the Intensive Care Units of a University Hospital |
Lee, Kyung Suk
(Department of Pediatrics, College of Medicine, Kyung Hee University)
Lee, Gyu Min (Department of Pediatrics, College of Medicine, Kyung Hee University) Yoon, Hoi Soo (Department of Pediatrics, College of Medicine, Kyung Hee University) Chung, Sa Jun (Department of Pediatrics, College of Medicine, Kyung Hee University) Cha, Sung-Ho (Department of Pediatrics, College of Medicine, Kyung Hee University) Chun, Hee-Kyung (Department of Infection Control, College of Medicine, Kyung Hee University) |
1 | Fulnecky EJ, Wright D, Scheld M, Kanawati L, Shoham S. Amikacin and colistin for treatment of Acinetobacter baumannii meningitis. J Infect 2005;51:e249-51. DOI ScienceOn |
2 | Chang PY, Hsueh PR, Wu PS, Chan PC, Yang TT, Lu CY, et al. Multidrug-resistant Acinetobacter baumannii isolates in pediatric patients of a university hospital in Taiwan. J Microbiol Immunol Infect 2007;40:406-10. |
3 | Tankovic J, Legrand P, De Gatines G, Chemineau V, Brun-buisson C, Duval J. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic methods. J Clin Microbiol 1994;32:2677-81. |
4 | Moon SM, Son JS, Lee HJ, Chun HK, Kim ML, Lee MS. The analysis of risk factor and infection control of carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit. Korean J Nosocomial Infect Control 2009;14:72-8. |
5 | Yang HY, Lee HJ, Suh JT, Lee KM. Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea. Yonsei Med J 2009;50:764-70. DOI ScienceOn |
6 | Lopez-Hernandez S, Alarcon T, Lopez-Brea M. Carbapenem Resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain. Eur J Clin Microbiol Infect Dis 1998;17:282-5. |
7 | Go ES, Urban C, Janice B, Kreiswirth B, Eisner W, Mariano N, et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polimyxin B and sulbactam. Lancet 1994;344:1329-32. DOI ScienceOn |
8 | Paton R, Miles RS, Hood J, Amyes SGB. ARI-1/betalactamase- mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 1993;2:81-8. DOI ScienceOn |
9 | Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002;8:687-93. DOI ScienceOn |
10 | Zhanel GG, DeCorby M, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, et al. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Diagn Microbiol Infect Dis 2008;62:67-80. DOI ScienceOn |
11 | Patzer JA, Dzierzanowska D, Turner PJ. Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007). J Antimicrob Chemother 2008;62:369-75. DOI ScienceOn |
12 | Hogg GM, Barr JG, Webb CH. In-vitro activity of the combination of colistin and rifampicin againts multidrug-resistant strains of Acinetobacter baumannii. J Antimicrob Chemother 1998;41:494-5. DOI ScienceOn |